Effect of low-frequency repetitive transcranial magnetic stimulation combined with physical therapy on L-dopa-induced painful off-period dystonia in Parkinson's disease.
Previous research has shown that low-frequency repetitive transcranial magnetic stimulation over the primary motor area and supplementary motor area can reduce L-dopa-induced dyskinesias in Parkinson's disease; however, it involved only patients with peak-dose or diphasic dyskinesia. We report a case of a patient with severely painful off-period dystonia in the unilateral lower limb who underwent 0.9-Hz subthreshold repetitive transcranial magnetic stimulation over contralateral primary motor area and supplementary motor area. Repetitive transcranial magnetic stimulation over the primary motor area significantly reduced the painful dystonia and walking disturbances but repetitive transcranial magnetic stimulation over the supplementary motor area did not. The cortical silent period also prolonged after repetitive transcranial magnetic stimulation over the primary motor area. At 5 mos of approximately once a week repetitive transcranial magnetic stimulation over the primary motor area, the Unified Parkinson's Disease Rating Scale motor score also improved. This report shows that repetitive transcranial magnetic stimulation over the inhibitory primary motor area can be useful for rehabilitating patients with Parkinson's disease with off-period dystonia and suggests that this treatment should be further verified in such patients.
Kodama
Mitsuhiko
M
Department of Rehabilitation Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Kasahara
Takashi
T
Hyodo
Masaki
M
Aono
Koji
K
Sugaya
Mutsumi
M
Koyama
Yuji
Y
Hanayama
Kozo
K
Masakado
Yoshihisa
Y
D000978:Antiparkinson Agents / Q000009:adverse effects*; D004421:Dystonia / Q000139:chemically induced / Q000628:therapy*; D019054:Evoked Potentials, Motor; D006801:Humans; D007980:Levodopa / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D010147:Pain Measurement; D010300:Parkinson Disease / Q000150:complications*; D050781:Transcranial Magnetic Stimulation
D000978:Antiparkinson Agents; D007980:Levodopa